• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Erratum: Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies [Corrigendum].勘误：卡立哌嗪在精神分裂症患者中的安全性和耐受性：八项II/III期研究的汇总分析[勘误]
Neuropsychiatr Dis Treat. 2021 May 17;17:1481. doi: 10.2147/NDT.S316858. eCollection 2021.
2
Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia: a pooled analysis of four phase II/III randomized, double-blind, placebo-controlled studies.卡立哌嗪用于精神分裂症急性加重患者的安全性和耐受性：四项II/III期随机、双盲、安慰剂对照研究的汇总分析
Int Clin Psychopharmacol. 2017 Nov;32(6):319-328. doi: 10.1097/YIC.0000000000000187.
3
The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis.卡立普嗪长期治疗精神分裂症的安全性和耐受性：一项事后汇总分析。
BMC Psychiatry. 2017 Aug 24;17(1):305. doi: 10.1186/s12888-017-1459-z.
4
Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled Trials.卡立普嗪治疗精神障碍、双相情感障碍和重度抑郁症的耐受性和安全性概况：一项随机对照试验的系统评价与荟萃分析
CNS Drugs. 2016 Nov;30(11):1043-1054. doi: 10.1007/s40263-016-0382-z.
5
Efficacy of cariprazine across symptom domains in patients with acute exacerbation of schizophrenia: Pooled analyses from 3 phase II/III studies.卡利拉嗪在精神分裂症急性加重期患者多个症状领域的疗效：来自 3 项 2/3 期研究的汇总分析。
Eur Neuropsychopharmacol. 2019 Jan;29(1):127-136. doi: 10.1016/j.euroneuro.2018.10.008. Epub 2018 Nov 20.
6
Evaluation of the long-term safety and tolerability of cariprazine in patients with schizophrenia: results from a 1-year open-label study.评估卡利拉嗪治疗精神分裂症患者的长期安全性和耐受性：一项为期 1 年的开放标签研究结果。
CNS Spectr. 2018 Feb;23(1):39-50. doi: 10.1017/S1092852917000220. Epub 2017 May 8.
7
Tolerability of cariprazine in the treatment of acute bipolar I mania: A pooled post hoc analysis of 3 phase II/III studies.卡利拉嗪治疗急性双相I型躁狂症的耐受性：三项II/III期研究的汇总事后分析
J Affect Disord. 2017 Jun;215:205-212. doi: 10.1016/j.jad.2017.03.032. Epub 2017 Mar 9.
8
Erratum: Pooled Analysis of Tanezumab Efficacy and Safety with Subgroup Analyses of Phase III Clinical Trials in Patients with Osteoarthritis Pain of the Knee or Hip [Corrigendum].勘误：骨关节炎疼痛的膝关节或髋关节患者的III期临床试验亚组分析中他奈单抗疗效和安全性的汇总分析[勘误]
J Pain Res. 2020 Sep 14;13:2267-2268. doi: 10.2147/JPR.S279856. eCollection 2020.
9
Erratum: An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder [Corrigendum].勘误：奥氮平/阿立哌唑用于治疗成人精神分裂症或双相I型障碍的循证综述[勘误说明]
Neuropsychiatr Dis Treat. 2021 Oct 15;17:3135-3136. doi: 10.2147/NDT.S340597. eCollection 2021.
10
Erratum: Neural Correlates of Cognitive Dysfunction in Conditional Reasoning in Schizophrenia: An Event-Related Potential Study [Corrigendum].勘误：精神分裂症条件推理中认知功能障碍的神经关联：一项事件相关电位研究[勘误]
Neuropsychiatr Dis Treat. 2024 Apr 6;20:835-836. doi: 10.2147/NDT.S472089. eCollection 2024.

勘误：卡立哌嗪在精神分裂症患者中的安全性和耐受性：八项II/III期研究的汇总分析[勘误]

Erratum: Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies [Corrigendum].

出版信息

Neuropsychiatr Dis Treat. 2021 May 17;17:1481. doi: 10.2147/NDT.S316858. eCollection 2021.

DOI:10.2147/NDT.S316858
PMID:34040374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8139728/
Abstract

[This corrects the article DOI: 10.2147/NDT.S301225.].

摘要

[本文更正了文章的数字对象标识符：10.2147/NDT.S301225。]